Cardiawave has been granted authorization by the ANSM
The French MedTech Cardiawave has been granted authorization by the Agence Nationale de Sécurité
Cardiawave has secured 8 million euros in funding
The French start-up Cardiawave has developed a highly innovative and non-invasive medical device
The world’s first non-invasive treatment of calcific aortic stenosis
It is a world premiere: French MedTech Cardiawave has successfully treated patients suffering from calcific aortic stenosis
Cardiawave obtains clinical trial authorization for the world’s first non-invasive treatment for aortic stenosis
Cardiawave, the MedTech company created following research conducted by the Institut Langevin and the HEGP (Georges Pompidou European Hospital)
Après l’obtention du prestigieux prix Galien Medstartup, Cardiawave en compétition pour le “Hello Tomorrow Global Challenge”
Après avoir remporté le prix Galien Medstartup le 25 octobre dernier, la MedTech Cardiawave
Cardiawave develops the world’s first non-invasive therapy for the aortic stenosis
Cardiawave, the startup created from the research work of the Langevin Institute and the Georges Pompidou